share_log

Caldwell Announces Passing of Board Chairman Elias Vamvakas

Caldwell Announces Passing of Board Chairman Elias Vamvakas

Caldwell宣布董事会主席Elias Vamvakas去世
Accesswire ·  07/11 16:30

TORONTO, ON / ACCESSWIRE / July 11, 2024 / Talent acquisition firm The Caldwell Partners International Inc. (TSX:CWL)(OTCQX:CWLPF) today announced with regret that Board Chairman Elias Vamvakas has passed away after a courageous battle with cancer.

2024年7月11日,人才招聘公司The Caldwell Partners International Inc.(TSX:CWL)(OTCQX:CWLPF)宣布董事会主席Elias Vamvakas在勇敢与癌症搏斗后去世,令人痛心。

"It is with a heavy heart that we announce Elias' passing," said John Wallace, chief executive officer. "Elias was a loyal leader of our Board, respected mentor to me and collaborative partner to our Board members. He offered wise guidance and support - especially through the global pandemic and ensuing downturn, adding tremendous value to our company, our strategy and our people. He was a great colleague and an even better friend, and I feel an immense sense of gratitude to him for his insight, his perspective, his leadership, and his guidance the past five years here at Caldwell. On behalf of our Board of Directors and the entire Caldwell team, we extend our deepest sympathies to Elias' family."

“我们怀着沉重的心情宣布Elias去世了,”首席执行官John Wallace说。“Elias是我们董事会的忠实领袖,我尊敬的导师,也是我们董事会成员合作伙伴。他提供了明智的指导和支持-特别是在全球疫情和随之而来的经济衰退期间,为我们的公司、我们的策略和我们的人员增加了巨大的价值。他是一位伟大的同事,更是一个更好的朋友,我对他在Caldwell工作的过去五年中所做出的洞察力、视角、领导力和指导深感感激。我们董事会和整个Caldwell团队谨向Elias的家人致以最深切的慰问。”

Mr. Vamvakas joined the Board in July of 2019 to fill the vacancy left by G. Edmund King's retirement. He was also the Chairman, CEO and founder of Greybrook Capital, a private equity firm focused on real estate and healthcare. Mr. Vamvakas was also chairman of Greenbrook-TMS NeuroHealth centers, (GTMS), the leading provider of TMS therapy in North America. He was also chairman of TearLab Corporation (TEAR), an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care. Prior to Greybrook Capital, Mr. Vamvakas co-founded TLCVision (TLCV,TLC) where he served as Chairman and CEO.

Vamvakas先生于2019年7月加入董事会填补G. Edmund King退休留下的空缺。他还是Greybrook Capital的董事长、首席执行官兼创始人,该公司专注于房地产和医疗保健的股权投资公司。Vamvakas先生还是Greenbrook-TMS NeuroHealth中心(GTMS)的主席,GTMS是北美领先的TMS疗法提供商。他还是TearLab Corporation(TEAR)的主席,该公司正在开发和商业化新型的实验室芯片技术,使眼科医生能够在诊疗中测试高度敏感和特异性的泪液生物标志物。在加入Greybrook Capital之前,Vamvakas先生共同创办了TLCVision(TLCV,TLC),并担任董事长兼首席执行官。

Mr. Vamvakas is survived by his wife, Nancy Vamvakas; their three children, Olivia, Megan, and Michael; his father, Antonios Vamvakas; and his mother-in-law, Susan Fenwick.

Vamvakas先生的妻子Nancy Vamvakas和他们的三个孩子Olivia、Megan和Michael、他的父亲Antonios Vamvakas以及他的岳母Susan Fenwick幸存下来。

About Caldwell Partners

关于Caldwell Partners

Caldwell Partners is a technology-powered talent acquisition firm specializing in recruitment at all levels. Through two distinct brands - Caldwell and IQTalent - the firm leverages the latest innovations in AI to offer an integrated spectrum of services delivered by teams with deep knowledge in their respective areas. Services include candidate research and sourcing through to full recruitment at the professional, executive and board levels, as well as a suite of talent strategy and assessment tools that can help clients hire the right people, then manage and inspire them to achieve maximum business results.

Caldwell Partners是一家利用最新的人工智能技术进行人才招聘的科技公司。通过两个不同的品牌——Caldwell和IQTalent——该公司利用其各自领域的深厚知识,提供由候选人调研和采购到在专业、执行和董事层面的全面招聘服务,以及一套人才战略和评估工具,帮助客户雇用合适的人才,然后管理和激励他们以实现最大的业务成果。

Caldwell Partners' common shares are listed on The Toronto Stock Exchange (TSX: CWL) and trade on the OTCQX Market (OTCQX: CWLPF). Please visit our website at for further information.

Caldwell Partners的普通股在多伦多证券交易所上市(TSX:CWL)并在OTCQX市场交易(OTCQX:CWLPF)。请访问我们的网站 以获取更多信息。

For further information, please contact:

如需更多信息,请联系:

Investors:
Chris Beck, President, and Chief Financial Officer
cbeck@caldwell.com
+1 (617) 934-1843

投资者:
Chris Beck,总裁兼首席财务官。
cbeck@caldwell.com
+1 (617) 934-1843

Media:
Caroline Lomot, Director of Marketing
clomot@caldwell.com
+1 (516) 830-3535

媒体:
市场营销总监卡罗琳·洛莫特
clomot@caldwell.com
+1 (516) 830-3535

SOURCE: Caldwell Partners International, Inc.

SOURCE: Caldwell Partners International, Inc.


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发